These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 26164096)

  • 41. Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy.
    Maes P; Delemarre J; de Kraker J; Ninane J
    Eur J Cancer; 1999 Sep; 35(9):1356-60. PubMed ID: 10658527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative chemotherapy for children with Wilms' tumor.
    Greenberg M; Burnweit C; Filler R; Weitzman S; Sohl H; Chan H; Jenkin D; Dougherty M; Berry M; Balcolm A
    J Pediatr Surg; 1991 Aug; 26(8):949-53; discussion 953-6. PubMed ID: 1656009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial.
    Powis M; Messahel B; Hobson R; Gornall P; Walker J; Pritchard-Jones K
    J Pediatr Surg; 2013 Nov; 48(11):2181-6. PubMed ID: 24210183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Better survival after combined modality care for adults with Wilms' tumor. A report from the National Wilms' Tumor Study.
    Arrigo S; Beckwith JB; Sharples K; D'Angio G; Haase G
    Cancer; 1990 Sep; 66(5):827-30. PubMed ID: 2167146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
    Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
    Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
    Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
    Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
    Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multimodal therapy for adult Wilms' tumour: an experience from one centre.
    Li JJ; Huang HH; Shen J; Jiang JY; Pan F; Yu ST; Kang Y; Zhao XX; Yan XC; Liang HJ
    Clin Transl Oncol; 2011 Sep; 13(9):672-6. PubMed ID: 21865139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Teratoid Wilms' tumor: case report of a rare variant that can mimic aggressive biology during chemotherapy.
    Treetipsatit J; Raveesunthornkiet M; Ruangtrakool R; Sanpaki K; Thorner PS
    J Pediatr Surg; 2011 Dec; 46(12):e1-6. PubMed ID: 22152898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival.
    Flentje M; Weirich A; Graf N; Pötter R; Zimmerman H; Ludwig R
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):163-9. PubMed ID: 9422573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of advanced Wilms' tumor].
    Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A retrospective study of the preoperative treatment of advanced Wilms tumor in children with chemotherapy versus transcatheter arterial chemoembolization alone or combined with short-term systemic chemotherapy.
    Li MJ; Zhou YB; Huang Y; Tang DX; Xu S; Wu DH; Zhang YY; Tang HF
    J Vasc Interv Radiol; 2011 Mar; 22(3):279-86. PubMed ID: 21353980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bilateral Wilms' tumor--surgical aspects.
    Paya K; Horcher E; Lawrenz K; Rebhandl W; Zoubek A
    Eur J Pediatr Surg; 2001 Apr; 11(2):99-104. PubMed ID: 11371044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I; van Tinteren H; Bergeron C; de Kraker J;
    Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
    Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
    J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
    Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
    Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH.
    Flentje M; Weirich A; Pötter R; Ludwig R
    Radiother Oncol; 1994 Jun; 31(3):222-8. PubMed ID: 8066205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies.
    Mifsud W; Furtwängler R; Vokuhl C; D'Hooghe E; Pritchard-Jones K; Graf N; Vujanić GM
    Eur J Cancer; 2022 May; 166():1-7. PubMed ID: 35255331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.